Healthcare Intelligence

7 of 10 tracked shares rose over 21 sessions. Regeneron led at +22.5%, but the equal-share group without it moved +4.7%. 9 of 10 companies report positive year-on-year sales growth in their latest available company record.

This page separates the healthcare index from its individual companies. It checks breadth, trading pressure, company results and what remains when the strongest share is removed.

PRICE
SALES
CASH
the market move crosses three checks
XLV · 21 sessions+5.5%Main listed benchmark
XLV · 63 sessions+5.8%Longer market window
Tracked shares rising7 of 10Latest 21 sessions
Above 50-day average8 of 10Current trend support
Beating XLV5 of 10Latest 21 sessions
Buying pressure positive7 of 10Price location and trading volume
Best performerREGN+22.5%
Best-to-worst gap26.7%REGN versus UNH
Move without leader+4.7%Equal share for each remaining name
Link with SPY+0.23Daily movement over 90 sessions
Short and longer view agree+0.54Cross-company rank relationship
Positive sales growth9 of 10Latest company records

Ask this page.

Choose a useful question or type your own. The answer and chart use only the figures already checked for this page.

Choose a question to build a chart.

Current viewWaiting for a question

The chart will appear here.

Is the move broad enough to trust?

Price, trend and trading pressure are shown together. Company sales, profit and cash use the latest available company record and may have different reporting dates.

CompanyShare21 sessions63 sessionsVersus XLV50-day trendBuying pressureFrom yearly highLatest sales growthProfit marginFree cash
RegeneronREGN+22.5%+13.9%+17.0%Above+0.18-3.4%+36.3%28.5%$2.6bn
Eli LillyLLY+14.3%+10.7%+8.8%Above-0.09-4.0%+38.6%31.9%$9.3bn
GileadGILD+11.2%+16.0%+5.8%Above+0.07-3.6%+6.8%-12.5%$10.7bn
Johnson & JohnsonJNJ+9.8%+2.4%+4.4%Above+0.05-4.0%+5.9%16.2%$18.5bn
AmgenAMGN+7.8%+4.1%+2.3%Above-0.03-5.4%+8.5%24.1%$7.4bn
AbbVieABBV+3.6%+10.8%-1.9%Above+0.06-3.3%+10.3%15.7%$17.7bn
Thermo FisherTMO+1.1%+12.0%-4.4%Above+0.07-5.6%+9.1%14.9%$6.4bn
MerckMRK-0.2%-5.2%-5.6%Below+0.04-8.6%+4.7%3.6%$14.0bn
Intuitive SurgicalISRG-0.6%+8.2%-6.1%Above-0.05-28.7%+21.7%25.5%$3.4bn
UnitedHealthUNH-4.2%+0.9%-9.7%Below+0.01-15.6%-0.4%3.5%$26.5bn

7 of 10 tracked shares rose over 21 sessions. Regeneron led at +22.5%, but the equal-share group without it moved +4.7%. 9 of 10 companies report positive year-on-year sales growth in their latest available company record.

What changes without the leader?

The strongest share is removed before the group is read again.

Equal-share group+6.5%
Without REGN+4.7%
REGN+22.5%

A good group move should not disappear when its best share is removed.

Research by for Charlie Quant Lab · Updated